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Abstract
Aim: To evaluate whether structured, nurse-led pro-active care of patients with chronic depression in
primary care improves outcomes.
Methods: Participants with chronic/recurrent major depression or dysthymia were recruited from 42 UK
general practices and randomised to GP treatment as usual or nurse intervention over 2 years.
Results: 282 people received the intervention with 276 controls. At 24 months there was no significant
improvement in Beck Depression Inventory (BDI-II) score or quality of life (Euroquol-EQ-VAS), but a
significant improvement in functional impairment (Work and Social Activity Schedule) of 2.5(95% CI:0.6,4.3,
p=0.010) in intervention patients. Impact per practice nurse intervention session was -0.37(95% CI:-0.68,-
0.07,p=0.017) on BDI-II and -0.33(95% CI:-0.55,-0.10,p=0.004) on WSAS scores, indicating that attending
all 10 intervention sessions could lead to a BDI-II score reduction of 3.7 points compared to controls.
Conclusion: The intervention improved functioning in these patients, the majority of whom had complex
long-term difficulties, but only had a significant impact on depressive symptoms in those engaging with the
full intervention.
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2Introduction:
Depression is an important public-health problem, and one of the leading causes of disease burden
worldwide1. The medical outcomes study collated data from 11,242 outpatients in the United States (US)
and showed that depressive symptoms, with or without major depressive disorder, impaired functional ability
and wellbeing as much as the most common chronic medical conditions such as diabetes, chronic lung
disease, hypertension, and heart disease2,3. After two years' follow up around 40% of those with major
depression were still affected and functionally impaired, while those with chronic minor depression
(dysthymia) had the worst outcome. Most had only partial recovery of functional ability3. Primary care
populations with chronic or recurrent depression, although clinically important, are rarely investigated as a
distinct patient group4. It is known that chronicity of depression is associated with high mortality, greater
psychological and social morbidity and high use of primary care services5, but there is little consistency
regarding longer-term management of this disorder6. Studies from the US indicate that organised, enhanced
care can have a beneficial effect on outcomes for patients with acute major depression7, and also those with
persistent depression8 or at high risk of recurrence9. However, there are increased costs associated with
such an approach and beneficial effects can decline over time, such that a longer-term approach may be
indicated, particularly for those with chronic difficulties10. Most people with depression are treated in primary
care, but there have been few trials of interventions targeted at those with chronic or recurrent depression in
either primary or secondary care settings, with most examining interventions for newly diagnosed
depression11. Collaborative care models include specialist input, which is potentially more costly to deliver
than models based solely in primary care. Given the associated unmet needs, significant morbidity and costs
there is a need for new approaches to management of this problem in primary care. The aim of this trial was
to evaluate the management of chronic depression with regular pro-active contact and follow-up of patients
by practice nurses over two years, supported by general practitioners (GPs).
Methods:
Objective:
To establish whether structured, pro-active care of patients with chronic depression in primary care leads to
an improvement in medical and social outcomes when compared with usual GP care.
Study design and participants:
Randomised controlled trial comparing GP ‘usual care’ (control), with a ‘pro-active care’ approach involving
regular follow-up by practice nurses (intervention) in addition to GP usual care, for patients with recurrent or
chronic depression (see protocol paper for details12). Participants were recruited from 42 general practices
throughout the United Kingdom (UK). Inclusion and exclusion criteria are shown below.
Inclusion criteria:
(i) Adults aged 18 and over
(ii) Two or more documented episodes of major depression within the previous 3 years
(iii) Evidence of recurrent and / or chronic depression via CIDI (lifetime) questionnaire13
(chronic depression was categorised as an episode of major depression lasting at least 2 years within the 3
years prior to recruitment or chronic dysthymia for the two years prior to recruitment)
(iv) Baseline Beck Depression Inventory score of 14 or above14
(v) Sufficient English to be able to complete self-report questionnaires
Exclusion criteria:
(i) Current psychotic symptoms
(ii) Impaired cognitive function
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Consent and randomisation:
After a thorough explanation of the study to potential subjects, written informed consent was obtained from
those fulfilling the inclusion criteria and agreeing to take part. Consenting participants were individually
randomised by telephone, using the independent Medical Research Council computerised randomisation
service and a blocked design to maintain a balance of numbers in control and intervention groups. All
participants completed baseline questionnaires at the practice prior to being informed about their
randomisation result by the research nurse. All study team members apart from the project manager were
blind to block size and group allocation.
Trial Intervention:
The intervention, termed ‘pro-active’ care, involved regular scheduled follow-up appointments with trained
nurses over the 24 months of the trial. Intervention participants had a baseline assessment and further
sessions were offered after 1 month, 2 months later and then every 3 months for the remainder of the 2
years of the trial, i.e. a total of 10 appointments. Most were face to face, although patients had the option to
elect for telephone appointments when attending the surgery was difficult. A joint management plan was
formulated between the nurses and each of their patients at the baseline assessment and reviewed during
subsequent appointments. If clinically indicated the reviews could be more frequent and if nurses were
concerned about a patient, they were asked to discuss them with the relevant GP, who might also see the
patient if indicated.
At each session the nurses asked about the patients’ current mood and reviewed their social circumstances,
current treatment (medication and / or psychological therapy), and any side-effects. They discussed
participants’ queries about current or past treatments and checked their concordance with treatment,
clarifying any reasons for poor concordance. If there were current symptoms of depression, alternative or
additional treatments were discussed. The nurses were given brief training in problem solving and
motivational interviewing techniques15,16 and used these to help the participants to identify their own
problems, solutions, motivation for change and preferences for care.
The intervention was manualised and has been described in detail elsewhere12. All participating nurses
received at least one quality assurance visit from a senior, independent MRC GP Research Framework
training nurse. Intervention participants were also given an educational booklet designed for the trial, which
included information about depression and outlined current evidence based thinking about its treatment (the
intervention manual and educational booklet are obtainable on request).
Nurse training and clinical supervision sessions:
The research team provided 3 days training for all participating practice nurses12. A further day’s training
was provided for nurses conducting the outcome assessments. Each nurse was assigned a member of the
research team as a ‘clinical supervisor’ (two were GPs with an interest in mental health and one a clinical
psychologist). Nurses had telephone contact every 3 to 4 months with their supervisors and could contact
them in between with any patient concerns.
Control arm – ‘treatment as usual’:
Participants in the control arm received ‘treatment as usual’ and continued to see their GP on request. They
did not see the practice research nurse for any mental health intervention.
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a) The primary outcome measure was the Beck Depression Inventory (BDI-II)14.
b) Functional impairment was measured using the Work and Social Activity Scale (WSAS)17.
c) Diagnostic and Statistical Manual IV (DSM-IV) diagnosis and frequency of depressive episodes assessed
using the Composite International Diagnostic Interview (CIDI) questionnaire13 at recruitment and follow-up.
d) Health-related quality of life measured using the EuroQuol EQ-5D18 Here we report results from the visual
analogue scale (EQ-VAS).
e) Practice service data on number of GP visits, practice nurse contacts, referrals for psychological therapy
and prescriptions for psychotropic medication collected for 24 months before recruitment and the 24 months
of the trial.
BDI-II results completed by self-complete questionnaire at baseline, 3, 6, 12, 18 and 24 months.
All other measures were collected at baseline and 24 months12.
The CIDI was completed via face to face interview with a practice research nurse at baseline and 2 years.
Final assessment interviews were conducted by research nurses not involved in delivering the intervention
who were blind to participants’ trial group allocations. As a check on blindness they were asked to estimate
which trial arm each participant had been randomised into.
Practice service use data was collected by practice nurses involved in the initial recruitment and delivery of
the intervention. All other outcome measures were obtained by self-complete questionnaires.
Sample size and statistical analysis:
Data were double entered and analysed using SPSS for Windows Release 15.0 and STATA Release 10.
The sample size was calculated to detect a clinically important difference in BDI-II at 90% power and the 5%
(two-sided level) of significance. A pooled standard deviation of 11.0 was assumed and the sample sizes
adjusted for clustering using an intra-class correlation (ICC) of 0.0219. For a 4-point difference in BDI
(assuming an average 10 patients per practice) the required sample size would be 376 (15). Thus 38
practices with 10 patients per practice (total 380) would meet the required sample size. In order to take
account of possible attrition, recruiting 12 to 14 patients per practice would allow for 25% attrition, meaning a
total of 532 participants would be required.
For continuous variables means and standard deviations were calculated, and for categorical variables
numbers and percentages. All analyses were undertaken on an intention to treat (ITT) basis. For the primary
(BDI-II) and secondary (WSAS and EQ-VAS) outcomes we used multi-level modelling adjusted for clustering
by general practice20. For the BDI-II the multi-level modelling included an additional level to take account of
repeated measures over time. All models fitted reflected the appropriate hierarchical structure of the data
and adjusted for baseline values of the relevant outcome. Practice service use data were analysed using
analysis of covariance (ANCOVA), adjusting for baseline values and using robust standard errors to account
for clustering21.
In order to calculate the effect sizes of the main outcome measures we used a method utilising estimates
derived from the multi-level models (Hedge’s g)22.
For the BDI-II, WSAS and EQ-VAS the effect of number of “nurse sessions” attended on outcome was also
assessed using a contamination adjusted intention to treat analysis (CA ITT)23. This was implemented using
instrumental variable (IV) regression with the 24 months follow-up score as the outcome, randomisation as
the IV, baseline score and number of sessions as explanatory variables and robust standard errors to take
account of clustering. A CA ITT analysis allows adjustment for non-adherence, avoiding the biases of as
treated and per-protocol analyses and preserving the randomness of allocation by examining how control
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CACE analysis (complier average causal effect
Results:
We approached 3,293 potentially eligible people from 42 general practices throughout the UK, identified
predominantly from practice database searches. Participants were recruited between November 2007 and
July 2008 and the 2 year follow-up continued until the end of July 2010.
Of 3,293 people initially approached, 959 (29%) expressed an interest in attending for interview and 828
(25%) attended. Following the recruitment interview and assessment 558 people were found eligible and
agreed to take part (Figure 1).
Figure 1 about here
Participants’ questionnaire responses for the primary outcome the BDI-II were: 99% at baseline; 72% at 3
months; 66% at 6 months; 66% at 12 months; 62% at 18 months and 78% at 24 months. Because of
concern about attrition between 3 and 6 months, following discussion at the Trial Steering Group and having
obtained ethical approval, we incentivised the return of questionnaires from the 12-month follow-up point
with £10 shopping vouchers24.
The 24 month outcome interviews were completed face to face with a different research nurse from the
nurse conducting the initial recruitment and intervention and participant response was 65%. A further 13% of
participants returned the final BDI-II by post. A total of 66 participants (12% of the total) formally withdrew
over the 24 months of the study; 36 in the intervention group and 30 in the control group. One participant in
the intervention arm died of cancer during the trial.
Number of sessions attended: Of the 282 participants in the intervention arm, 77 (27%) were poor
attenders and only attended 0-4 intervention sessions, 83 (29%) were moderate attenders and attended 5-8
sessions and 122 (43%) were good attenders, having attended 9-11 intervention sessions. The latter group
were considered to have attended for the full intervention as various timing constraints meant that not all
could be offered the full 10 sessions initially intended.
Baseline characteristics
The two groups were well balanced with respect to baseline characteristics, with no large differences
between the intervention and control groups (Table 1).
Table 1 about here
Outcome results at 24 months
Primary outcome: Scores for the BDI-II at follow-up improved (decreased) in both trial arms over time
(Table 2). There was a small but not significantly greater improvement in the intervention arm. The estimated
average difference in score, from the multi-level modelling, was lower [better] by 1.2 (95% CI: -0.3, 2.7,
p=0.125) in the intervention group when accounting for all time-points.
Table 2 about here
Secondary outcomes: Summary results at 24 months are presented in Table 3. From the multi-level
modelling, the WSAS score was found to be significantly lower [better] by 2.5 (95% CI: 0.6, 4.3, p=0.010) in
6the intervention group at 24 months, while the EQ-VAS score was higher [better]) by 2.9 (95% CI: -0.8, 6.5,
p=0.127) in the intervention group at 24 months.
Table 3 about here
The only statistically significant differences in service use were for practice nurse visits and number of
months on antidepressants. Both were higher in the intervention group, with adjusted mean differences
(intervention-control) of 1.6 (95% CI: 0.2, 3.0; p=0.026) and 1.4 (95% CI: 0.02, 2.8; p=0.047) respectively.
A comparison of the proportions in each diagnostic category (CIDI) between intervention and control groups
at follow-up showed no statistically significant difference (p=0.368).
Effect sizes: Using Hedge’s g method gave us the effect sizes: BDI-II = 0.09; WSAS = 0.21; EQVAS = 0.14
CA ITT analysis: Results investigating the effect of the number of intervention sessions on BDI-II, WSAS
and EQ-VAS scores using the CAITT analysis showed the following “per nurse treatment-session ” effects
on average score: BDI-II (-0.37, 95% CI: -0.68,-0.07, p=0.017), WSAS (-0.33, 95% CI: -0.55,-0.10, p=0.004)
and EQ-VAS (0.38, 95% CI: -0.13,0.88, p=0.142), indicating statistically significant improvements
(decreases) per session in BDI-II and WSAS scores of -0.37 and -0.33, respectively. We then multiplied the
per session effect by the number of sessions attended, which would lead to a reduction in BDI-II score of 3.7
points and a reduction in WSAS scores of 3.3 points more in intervention patients than controls if all 10
intervention sessions were attended. This assumes from the analysis that each session is likely to have the
same effect on outcome and thus the effect of the sessions attended is additive.
Masking of the final assessment: Agreement between the trial arm allocation and guesses of the
research nurses undertaking the final patient assessment (n=361) was low (kappa=0.281, p<0.001),
indicating successful blinding of the outcome assessments.
Discussion:
Principal findings
There was no significant improvement in depression score (BDI-II) or quality of life (EQ-5D) at 24 months
follow-up in the overall sample, but there was an improvement in social functioning (WSAS). The
contamination adjusted intention to treat analysis (CA ITT), conducted to assess the effect of the number of
sessions received, demonstrated a positive per session effect for both BDI-II and WSAS scores. From this
CA ITT analysis it could be inferred that patients attending all 10 intervention sessions might be expected to
reduce their BDI-II score by 3.7 points more than control patients.. Given the chronicity of this patient group
and the severity of their baseline depression and functional impairment, this improvement is encouraging.
The higher level of nurse visits in the intervention group was expected, given the nature of the intervention.
Both groups had very high levels of GP contact at baseline, which dropped slightly at follow-up, but were not
significantly different between the two groups. Antidepressant usage dropped slightly in both groups over the
follow-up period, but was significantly higher in the intervention group. There was no evidence that outcome
varied by baseline diagnostic group.
Strengths and limitations
A particular strength was our large, nationally representative sample. The intervention was manualised,
straightforward to implement and underwent successful piloting before the trial. Patients were rigorously
assessed using standard diagnostic instruments, quality assurance for delivery of the intervention and
outcome assessments was ensured and research blinding maintained. The study was conducted across 42
UK general practices, but with fewer practices from deprived ethnically diverse inner city areas resulting in a
low proportion of participants from black and minority ethnic groups, so the results may be less applicable to
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interviews, which might be a limitation as regards generalisability, but analysis of our baseline data indicated
that those participating were a severely affected and highly morbid group25. This was also reflected in their
high rates of GP visits at baseline, which were nearly three times higher than general population figures26.
There was some attrition over the trial period (74% completed 24 month assessments), although this is
reasonable for this population and similar to other studies10.
In our pilot trial there were no identified issues of contamination. There was very little contact between the
practice nurses and control patients, and where this occurred they were reviewed exclusively for physical
health problems. There may have been a small risk of contamination in the main trial, which if present would
lead to an underestimation of the effectiveness of the intervention.
Implications of these findings with reference to other studies
Our trial focused on the practice nurse as case manager within a chronic care model, with primary care
support but, unlike US models of collaborative care, no input from specialist mental health services apart
from for individual patients as part of their routine clinical care. This model is similar to that shown to be
effective and in widespread use for other long-term conditions such as diabetes and COPD27, and could be
more easily implemented in a primary care setting using existing staff, such as practice nurses with no
previous specific training in mental health. Practice nurses are available in many health care systems and
achieve good results in managing other long-term conditions28. However, their training has been inadequate
for working with people with mental health problems29, which was something we aimed to address with a
focused, brief training course and clinical supervision over the study period.
A systematic review of randomised controlled trials of case management for depression in primary care
highlighted a range of factors likely to be associated with a positive outcome, several of which were present
in this trial30. Systematic tracking of patients by a provider other than the doctor was significantly associated
with improved depression outcomes and could be further improved by incorporating patient preferences into
care, which were both factors we included. Practice nurses in our trial received brief training in simple
problem solving and motivational interviewing techniques15,16. Our qualitative evaluation indicated they used
a problem-solving approach but made little use of motivational interviewing techniques in delivering the
intervention31. They were encouraged not to consider themselves as therapists delivering a psychological
intervention, but to refer patients to local psychological therapy services if indicated. However, they reported
that access to psychological therapies was often not readily available for their patients, and their role in
facilitating access to such treatments was therefore limited. Increased availability of appropriate, evidence
based psychological therapies might have improved patient outcomes.
Our results suggest improvements in functioning were greater than changes in symptoms of depression. This
positive impact on functional impairment may be particularly important as there is evidence it is more
significant in those with moderate to severe depression32. Whilst the functional impairment and disability
associated with depression is often noted, there is relatively little emphasis on treatments which may positively
impact on this33,34. If participants engaged with the intervention and attended all the review sessions they had
statistically significant improvements per session in both depressive symptoms and functional impairment. The
two are likely to be linked and, although traditionally it is often considered that an improvement in mood leads
to improved functioning, the converse may also be the case and it may be that in the context of chronic
depression it may be possible to improve functioning without great improvements in depressive symptoms.
The absolute difference in functioning (WSAS) score in our study was modest, and its clinical significance is
unclear. However the results from our linked qualitative study gives support to some patients reporting
meaningful changes in functioning resulting from the intervention35. Most participants reported an impact on
some aspect of their lifestyle, with potential impacts on diet, increasing exercise and sleep.
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Systematic reviews of randomised trials involving patients with depression in primary care or community
settings have included predominantly acute cases11. Our population was more chronic and morbid and
potentially more difficult to treat25, with very high baseline rates of GP consultations. Practice nurses are a
widespread resource and in regular contact with such patients for their physical care, but often feel poorly
skilled in working with mental health problems29. The training we provided was very well received31 and we
would encourage more widespread development of specific, and if possible more intensive, training courses
for practice nurses in common mental health problems. We allowed the nurses to decide which approach to
take with the patients with reference to the training they had received, but the training was of necessity brief
and it would be interesting to see whether a more prescriptive approach to the management of these
patients would give different results.
A difficult initial interaction with the nurse, patients who appeared to lack the motivation or time to attend
appointments, were reluctant to discuss their difficulties or felt pessimistic that their situation might improve
were all factors linked with poor attendance and such patients had poorer outcomes31. It may be appropriate
for patients who do not engage well with the practice nurse as case manager to see someone with a mental
health background in this role. Our trial suggests participants who engaged well and attended all sessions had
more positive outcomes, irrespective of the severity or chronicity of their depression at baseline. We obtained
useful information from our qualitative work, suggesting early development of rapport with the practice nurse
and motivation to change were important features of engagement31. This has implications for clinicians
considering patient suitability for this type of service.
Our findings indicate that practice nurse-led enhanced care for chronic and recurrent depression shows
promise for motivated patients from this highly morbid group in primary care. This model of care may have
value in other health care systems with limited access to secondary care psychology or psychiatric services
and should be evaluated in these settings.
Conclusions
Patients with chronic or long-term depression are a neglected group as regards both clinical management
and research into effective interventions. In our trial, whilst overall improvements in depressive symptoms
were small and non-significant for patients receiving the intervention, there were significant improvements in
work and social functioning. Further supplementary analysis indicated patients who regularly attended
sessions over two years did well, with improvements in both depressive symptoms and functioning. In any
implementation, it is key to identify patients more likely to engage with and benefit from such an intervention.
The nurses’ focus and approach on practical goals and problem solving may have contributed to the
improved levels of functioning obtained.
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Figure 1: Consort Diagram: Recruitment and treatment group allocation
Enrolment
Allocation
Follow-up
Analysis
Invited to participate (n = 3,293)
Scheduled for recruitment interview
(n = 959)
Attended recruitment interview (n = 828)
Cancelled / did not attend
recruitment interview (n = 131)
Excluded (n = 270)
-Ineligible (score below 14 on BDI-II n=157)
-Ineligible (not meeting CIDI criteria n = 83)
- Chose not to participate (n= 30)
Included and randomised (n=558)
Allocated to pro-active care intervention
(n=282)
Allocated to control group
(n=276)
Potential participants identified (n = 3,293)
-Computer search (n=2,974)
-GP (n=188)
-Poster/ self-referral (n=34)
-No information (n=97)
Declined to participate (n = 2,334)
-Not depressed (144)
-No time/moving away (80)
-Not interested (62)
-Doesn’t want to talk (39)
-Happy with treatment (21)
-Too unwell (13)
-Copes alone (11)
-Other (29)
-No information (1935)
Withdrawals (n = 30)
- Felt better (1)
- No reason given (13)
- Upset by study (8)
- Study not useful (3)
- Physical illness (5)
Drop-outs (n=11)
Died (n = 0)
Withdrawals (n = 36)
- Felt better (2)
- No reason given (16)
- Upset by study (11)
- Study not useful (3)
- Physical illness (4)
Drop-outs (n=14)
Died (n = 1)
Included in primary analysis (n = 235) Included in primary analysis (n = 251)
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Table 1 - Baseline socio-demographic characteristics, diagnoses, symptoms, function and health
services utilisation. (Service use data refers to the 24 months prior to the baseline assessment).
Intervention Control
Age (years) Mean
(StandardDeviation : S.D)
48.3 (12.3) 48.4 (13.4)
Gender Female 217 (77.0%) 201 (72.8%)
Marital Status Married 133 (47.7%) 127 (46.9%)
Living with Partner/children 212 (76.3%) 188 (69.1%)
Accommodation Owner-occupied 188 (68.6%) 179 (66.1%)
Ethnicity White UK 251 (90.6%) 241 (89.3%)
Employment Paid 137 (48.9%) 121 (44.8%)
Diagnosis (CIDI) Chronic major depression 78 (28.1%) 86 (31.6%)
Recurrent depression 155 (55.8%) 142 (52.2%)
Dysthymia 45 (16.2%) 44 (16.2%)
BDI-II Mean (S.D.)
Number (N)
31.9 (9.8)
278
33.1 (10.6)
272
WSAS Mean (S.D.)
N
22.1 (9.6)
280
22.4 (9.4)
272
EQ-VAS Mean (S.D.)
N
54.5 (19.5)
281
52.8 (20.1)
269
GP visits Mean (S.D.)
N
15.5 (9.9)
270
15.8 (9.7)
271
GP home visits Mean (S.D.)
N
0.2 (1.2)
236
0.2 (0.9)
224
Practice nurse visits Mean (S.D.)
N
3.9 (4.7)
258
4.5 (5.1)
254
Practice counsellor visits Mean (S.D.)
N
0.7 (2.6)
258
0.4 (1.4)
254
Referrals to psychological
therapy/psychotherapy
Mean (S.D.)
N
0.4 (0.9)
155
0.3 (0.6)
145
Referrals to psychiatrist
/community mental health
team
Mean (S.D.)
N
0.4 (0.7)
154
0.6 (1.8)
154
Number of months on
antidepressants
Mean (S.D.)
N
14.1 (8.8)
267
12.7 (8.3)
269
CIDI : Composite International Diagnostic Interview; BDI-II : Beck Depression Inventory; WSAS : Work and
Social Activity Scale; EQ-VAS : Euroquol Visual Analogue Scale
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Table 2 - BDI-II scores across follow-up times
3 months 6 months 12 months 18 months 24 months
Control
(n = Number)
Mean (S.D.)
n
29.2 (12.8)
180
28.8 (13.8)
167
27.9 (13.6)
166
27.3 (13.6)
152
26.0 (14.9)
206
Intervention
(n = Number)
Mean (S.D.)
n
28.1 (12.3)
221
25.8 (12.7)
201
25.2 (12.8)
201
25.1 (14.4)
196
22.1 (14.2)
224
S.D. : Standard Deviation
Table 3 – Outcomes at 24 months follow-up
(Service use data refers to the 24 months prior to the 24 month follow-up assessment).
Intervention Control
WSAS Mean (S.D.)
n
16.2 (12.1)
224
18.8 (12.1)
205
EQ-VAS Mean (S.D.)
n
61.7 (21.6)
214
58.0 (21.4)
201
GP visits Mean (S.D.)
n
13.7 (9.5)
234
13.4 (9.1)
226
GP home visits Mean (S.D.)
n
0.1 (0.6)
193
0.1 (0.5)
190
Practice nurse visits Mean (S.D.)
n
5.5 (6.6)
234
4.8 (6.6)
226
Practice counsellor visits Mean (S.D.)
n
0.7 (2.1)
234
0.4 (1.6)
226
Referrals to psychological
therapy/psychotherapy
Mean (S.D.)
n
0.6 (1.2)
133
0.3 (0.6)
119
Referrals to psychiatrist
/community mental health team
Mean (S.D.)
n
0.6 (1.4)
117
0.4 (0.8)
126
Number of months on
antidepressants
Mean (S.D.)
N
13.6 (9.7)
261
11.7 (9.6)
250
Diagnosis (CIDI) Chronic major
depression
27 (13.8%) 28 (16.6%)
Recurrent depression 87 (44.4%) 60 (35.5%)
Dysthymia 25 (12.8%) 27 (16.0%)
No episodes of
depression
57 (29.1%) 54 (32.0%)
WSAS : Work and Social Activity Scale; EQ-VAS : Euroquol Visual Analogue Scale
